Pages that link to "Q27681806"
Jump to navigation
Jump to search
The following pages link to Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign (Q27681806):
Displaying 50 items.
- Harnessing the protective potential of HIV-1 neutralizing antibodies (Q26766153) (← links)
- Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site (Q27319450) (← links)
- Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1 (Q27322403) (← links)
- HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization (Q27324184) (← links)
- Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers (Q28263063) (← links)
- Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies (Q28553360) (← links)
- HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers (Q28647225) (← links)
- HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies (Q33753573) (← links)
- HIV-1 Env-specific memory and germinal center B cells in C57BL/6 mice (Q34303547) (← links)
- Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies (Q34594905) (← links)
- Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex (Q34709433) (← links)
- Identification of novel viral receptors with cell line expressing viral receptor-binding protein (Q34990603) (← links)
- A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene (Q35110976) (← links)
- Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation (Q35169535) (← links)
- Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties (Q35540033) (← links)
- Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization (Q35691113) (← links)
- A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS (Q35925858) (← links)
- Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (Q35985519) (← links)
- Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity (Q36086357) (← links)
- Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis (Q36245216) (← links)
- Phenotypic Correlates of HIV-1 Macrophage Tropism (Q36281817) (← links)
- Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. (Q36290038) (← links)
- Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction (Q36303368) (← links)
- Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region (Q36334312) (← links)
- Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens (Q36434196) (← links)
- HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation (Q36583109) (← links)
- Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. (Q36627503) (← links)
- High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence. (Q36905471) (← links)
- High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells. (Q36957800) (← links)
- Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates (Q37300461) (← links)
- Native-like Env trimers as a platform for HIV-1 vaccine design (Q37633417) (← links)
- Insights into the trimeric HIV-1 envelope glycoprotein structure (Q38323609) (← links)
- HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies (Q38665463) (← links)
- Evolution of B cell analysis and Env trimer redesign (Q38992740) (← links)
- The ClusPro web server for protein-protein docking (Q39024817) (← links)
- Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem (Q39108730) (← links)
- The HIV-1 envelope glycoprotein structure: nailing down a moving target (Q39108789) (← links)
- Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response (Q40043429) (← links)
- Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability. (Q40056179) (← links)
- HIV-1 Cross-reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Non-human Primate (Q40073016) (← links)
- Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach (Q40198048) (← links)
- HIV: A stamp on the envelope (Q40344733) (← links)
- An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes. (Q40463159) (← links)
- Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers. (Q40471380) (← links)
- Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design (Q41042362) (← links)
- Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers (Q41447893) (← links)
- Recent advances in retroviruses via cryo-electron microscopy. (Q50355158) (← links)
- Production of complex viral glycoproteins in plants as vaccine immunogens (Q56398263) (← links)
- HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth (Q59811711) (← links)
- The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256 (Q60301724) (← links)